文献速递泌尿系结石

无阿片类药物输尿管镜术:学术型泌尿科医生是否落后于私人执业

Opioid-Free Ureteroscopy: Are Academic Urologists Lagging Behind Private Practice?
PubMed 文献 · Urology · 2022-06-30

该回顾性研究分析了2016至2019年四个时间点本系统内555例输尿管镜术后的阿片类药物处方趋势,比较私人执业与学术机构,并评估一项无关的肿瘤手术阿片减量倡议的溢出效应。结果显示两类机构处方量均下降,但私人执业中位口服吗啡当量从60降至0并维持,学术机构2019年才降至0。

要点

  • 私人执业输尿管镜术后中位口服吗啡当量从2016-2017年的60降至0并维持至研究结束。
  • 学术机构阿片减量滞后于私人执业,但中位口服吗啡当量在2019年稳步降至0。
  • 未观察到来自无关肿瘤手术阿片减量倡议的显著溢出效应。

核心结论

  • 自2016年以来,私人执业与学术机构输尿管镜术后阿片处方均减少,私人执业泌尿科医生比学术泌尿科医生早2年达到中位0片阿片类药物,数据提示学术机构对阿片流行反应可能较慢。

研究设计与样本

  • 回顾性病历审查,纳入本系统内2016至2019年四个不同时间点所有输尿管镜术,共555例患者和29名主治外科医生,比较社区医院与学术医院及倡议前后。

主要发现

  • 私人执业中位口服吗啡当量从2016-2017年的60降至0,并在研究期间维持0。
  • 学术机构中位口服吗啡当量稳步下降,至2019年降至0。
  • 未观察到显著溢出效应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine overall trends in opioid prescribing after ureteroscopy and compared opioid use between private and academic practice settings. We also analyzed the potential for spillover effect from an unrelated opioid-reduction initiative for major oncologic surgery. METHODS: We conducted a retrospective chart review of all ureteroscopies performed within our system at four distinct time points from 2016-2019. We recorded the type and number of opioid pills prescribed and calculated oral morphine equivalents. Analysis included comparison between community and academic hospitals as well as pre- and post-initiative. RESULTS: 555 patients undergoing ureteroscopy and 29 attending surgeons were included in the analysis. The median prescription size per ureteroscopy decreased throughout the study period in both the private and academic settings. From 2016-2017, median oral morphine equivalents (OMEs) decreased from 60 to 0 in the private setting and remained at 0 for the duration of the study period. Opioid reduction in the academic setting lagged behind private practitioners but median OMEs did steadily decrease to 0 in 2019. No significant spillover effect was observed. CONCLUSION: Since 2016, opioid prescribing following ureteroscopy has decreased in both the private and academic practice settings. Notably, private practice urologists achieved a median of 0 opioids 2 years prior to academic urologists. These data suggest that, in some circumstances, academic institutions may have been slower to respond to the opioid epidemic.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Jones CA, Pekala KR, Armann KM, et al. Opioid-Free Ureteroscopy: Are Academic Urologists Lagging Behind Private Practice? Urology. 2022. PMID: 35780945. doi:10.1016/j.urology.2022.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。